- Home
- HP vs ACAD Comparison
HP vs ACAD Comparison
Compare HP & ACAD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HP
- ACAD
- Stock Information
- Founded
- HP 1920
- ACAD 1993
- Country
- HP United States
- ACAD United States
- Employees
- HP N/A
- ACAD N/A
- Industry
- HP Oil & Gas Production
- ACAD Biotechnology: Pharmaceutical Preparations
- Sector
- HP Energy
- ACAD Health Care
- Exchange
- HP Nasdaq
- ACAD Nasdaq
- Market Cap
- HP 2.6B
- ACAD 2.8B
- IPO Year
- HP N/A
- ACAD 2004
- Fundamental
- Price
- HP $26.13
- ACAD $16.61
- Analyst Decision
- HP Hold
- ACAD Buy
- Analyst Count
- HP 10
- ACAD 17
- Target Price
- HP $36.11
- ACAD $24.00
- AVG Volume (30 Days)
- HP 1.5M
- ACAD 1.5M
- Earning Date
- HP 04-23-2025
- ACAD 05-07-2025
- Dividend Yield
- HP 3.83%
- ACAD N/A
- EPS Growth
- HP N/A
- ACAD N/A
- EPS
- HP 3.03
- ACAD 1.36
- Revenue
- HP $2,756,762,000.00
- ACAD $957,797,000.00
- Revenue This Year
- HP $37.02
- ACAD $13.07
- Revenue Next Year
- HP $11.78
- ACAD $9.97
- P/E Ratio
- HP $8.63
- ACAD $12.28
- Revenue Growth
- HP N/A
- ACAD 31.85
- 52 Week Low
- HP $23.80
- ACAD $14.15
- 52 Week High
- HP $44.11
- ACAD $20.68
- Technical
- Relative Strength Index (RSI)
- HP 49.71
- ACAD 36.91
- Support Level
- HP $24.65
- ACAD $16.86
- Resistance Level
- HP $26.41
- ACAD $17.31
- Average True Range (ATR)
- HP 0.86
- ACAD 0.51
- MACD
- HP 0.26
- ACAD -0.00
- Stochastic Oscillator
- HP 84.27
- ACAD 23.24
About HP Helmerich & Payne Inc.
Helmerich & Payne Inc provides performance-driven drilling solutions and technologies that are intended to make hydrocarbon recovery safer and more economical for oil and gas exploration and production companies. The Company focus on the drilling segment of the oil and gas production value chain. Company operates in North America, Gulf of Mexico, and other international places such as Argentina, Australia, Bahrain, Colombia and the United Arab Emirates (UAE). Also own and operates a limited number of commercial real estate properties located in Tulsa, Oklahoma. It's real estate investments include a shopping center and of undeveloped real estate projects.
About ACAD ACADIA Pharmaceuticals Inc.
Acadia Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of medicines that address unmet medical needs in central nervous system (CNS) disorders and rare diseases. It has two core franchises in neuroscience and neuro-rare diseases. The neuroscience franchise is anchored by its commercial product NUPLAZID (pimavanserin), which is used for the treatment of hallucinations and delusions associated with Parkinson's Disease Psychosis (PDP). The neuro-rare disease franchise is anchored by the commercial product DAYBUE, which is used for the treatment of Rett syndrome. In addition, the company has various product candidates under development in different stages, including ACP-204, ACP-101, ACP-211, ACP-711, ACP-2591, etc.